Literature DB >> 16195773

An unusual case of posttransplant peritoneal primary effusion lymphoma with T-cell phenotype in a HIV-negative female, not associated with HHV-8.

Ioannis Venizelos1, Demetrio Tamiolakis, Maria Lambropoulou, Sylva Nikolaidou, Sophia Bolioti, Hlias Papadopoulos, Nikolas Papadopoulos.   

Abstract

Primary effusion lymphoma (PEL) is a recently individualized form of non-Hodgkin's lymphoma (WHO classification) that mainly develops in HIV infected males, more frequently in homosexuals and advanced stages of the disease (total CD4+ lymphocyte count below 100-200/microL). Occasionally, it appears in other immunodepressive states (such as solid organs transplant period) and even, although very rarely, in immunocompetent patients. From a pathogenetic point of view, PEL has been related to Kaposi's sarcoma associated herpes virus (also named human herpesvirus 8, HHV-8), an etiological factor of Kaposi's sarcoma. The relative infrequency of this disease, the absence of wide casuistics allowing a better characterization, and its unfavorable outcome support the need of a deeper knowledge. We present here the clinical-biological findings of a patient, HIV seronegative, who was diagnosed with peritoneal PEL of T-cell origin, and not HHV-8-associated, five years after renal transplantation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16195773     DOI: 10.1007/bf02893396

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  11 in total

Review 1.  Human herpes virus-8 associated primary effusion lymphoma of the pleural cavity in HIV-negative elderly men.

Authors:  V Ascoli; C C Scalzo; C Danese; K Vacca; A Pistilli; F Lo Coco
Journal:  Eur Respir J       Date:  1999-11       Impact factor: 16.671

Review 2.  The pathologic and clinical spectrum of anaplastic large cell lymphoma and correlation with ALK gene dysregulation.

Authors:  M C Kinney; M E Kadin
Journal:  Am J Clin Pathol       Date:  1999-01       Impact factor: 2.493

3.  p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia.

Authors:  G Gaidano; P Ballerini; J Z Gong; G Inghirami; A Neri; E W Newcomb; I T Magrath; D M Knowles; R Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

4.  Chromosomal and comparative genomic analyses of HHV-8-negative primary effusion lymphoma in five HIV-negative Japanese patients.

Authors:  Koichi Ohshima; Masako Ishiguro; Satoshi Yamasaki; Junichi Miyagi; Seichi Okamura; Yasuhiro Sugio; Tsutomu Muta; Hidenori Sasaki; Takeshi Tuchiya; Chika Kawasaki; Masahiro Kikuchi
Journal:  Leuk Lymphoma       Date:  2002-03

5.  Herpesvirus 8 inclusions in primary effusion lymphoma: report of a unique case with T-cell phenotype.

Authors:  J W Said; I P Shintaku; H Asou; S deVos; J Baker; G Hanson; E Cesarman; R Nador; H P Koeffler
Journal:  Arch Pathol Lab Med       Date:  1999-03       Impact factor: 5.534

6.  Molecular profile of Epstein-Barr virus infection in HHV-8-positive primary effusion lymphoma.

Authors:  L Fassone; K Bhatia; M Gutierrez; D Capello; A Gloghini; R Dolcetti; D Vivenza; V Ascoli; F Lo Coco; L Pagani; G Dotti; A Rambaldi; M Raphael; U Tirelli; G Saglio; I T Magrath; A Carbone; G Gaidano
Journal:  Leukemia       Date:  2000-02       Impact factor: 11.528

7.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

Authors:  Y Chang; E Cesarman; M S Pessin; F Lee; J Culpepper; D M Knowles; P S Moore
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

8.  Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus.

Authors:  D Frank; E Cesarman; Y F Liu; R E Michler; D M Knowles
Journal:  Blood       Date:  1995-03-01       Impact factor: 22.113

9.  An unusual case of primary effusion lymphoma in a HIV-negative patient not pathogenetically associated with HHV8.

Authors:  Masaru Shimazaki; Miri Fujita; Kenichi Tsukamoto; Takayuki Matsuki; Michihiro Iwata; Hiroshi Takahashi; Atsushi Doi; Masaya Hyakkoku; Kazuaki Yamauchi; Satoshi Genda; Tsuyoshi Kikuiri; Takashi Sakamoto; Shuichi Nojiri; Takeshi Ashie
Journal:  Eur J Haematol       Date:  2003-07       Impact factor: 2.997

10.  Anaplastic large cell lymphoma presenting as a pleural effusion and mimicking primary effusion lymphoma. A report of 2 cases.

Authors:  Alexander Chak-Lam Chan; John Kwok-Cheung Chan; Kin Wing Yan; Yok Lam Kwong
Journal:  Acta Cytol       Date:  2003 Sep-Oct       Impact factor: 2.319

View more
  5 in total

Review 1.  KSHV/HHV8-negative effusion-based lymphoma, a distinct entity associated with fluid overload states.

Authors:  Serge Alexanian; Jonathan Said; Mark Lones; Sheeja T Pullarkat
Journal:  Am J Surg Pathol       Date:  2013-02       Impact factor: 6.394

2.  Report of an HIV and HHV-8 negative case of primary effusion lymphoma with idiopathic T4 lymphocytopenia.

Authors:  Nikolaos J Tsagarakis; Aspasia Argyrou; Georgios Gortzolidis; Nektaria Kentrou; Stefanos I Papadhimitriou; Konstantina Tzanetou; Georgios Kakiopoulos; Konstantinos A Papadimitriou; Dimitra Skoumi; Georgios Paterakis
Journal:  Int J Hematol       Date:  2009-05-30       Impact factor: 2.490

3.  HHV8-Negative Primary Effusion Lymphoma of B-Cell Lineage: Two Cases and a Comprehensive Review of the Literature.

Authors:  Neeraj Saini; Ephraim P Hochberg; Erica A Linden; Smita Jha; Heinz K Grohs; Aliyah R Sohani
Journal:  Case Rep Oncol Med       Date:  2013-01-16

4.  An unusual case of Primary Effusion Lymphoma with aberrant T-cell phenotype in a HIV-negative, HBV-positive, cirrhotic patient, and review of the literature.

Authors:  Charitini Nepka; Dimitrios Kanakis; Maria Samara; Andreas Kapsoritakis; Spyridon Potamianos; Maria Karantana; Georgios Koukoulis
Journal:  Cytojournal       Date:  2012-06-29       Impact factor: 2.091

Review 5.  Primary Effusion Lymphoma: A Timely Review on the Association with HIV, HHV8, and EBV.

Authors:  Chih-Yi Liu; Bo-Jung Chen; Shih-Sung Chuang
Journal:  Diagnostics (Basel)       Date:  2022-03-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.